Douglas Faller
Chief Tech/Sci/R&D Officer bij ORYZON GENOMICS S.A.
Profiel
Douglas Faller is the founder of HemaQuest Pharmaceuticals, Inc. (founded in 2007).
Dr. Faller is also the founder of Viracta Subsidiary, Inc., Sapientia Pharmaceuticals, Inc...
Dr. Faller's current job is as a Professor at Boston University and as the Global Chief Medical Officer at Oryzon Genomics SA (since 2022).
Dr. Faller's former jobs include being an Executive Medical Director at Takeda Farmacéutica España SA, a Faculty Member at Dana-Farber Cancer Institute, Inc., a Faculty Member at The University of California, San Francisco, and the Chief Medical & Scientific Officer at Viracta Therapeutics, Inc. Dr. Faller's education includes a doctorate from Harvard University, undergraduate and doctorate degrees from Massachusetts Institute of Technology, and a graduate degree from The University of California, San Francisco.
Actieve functies van Douglas Faller
| Bedrijven | Functie | Begin |
|---|---|---|
| ORYZON GENOMICS S.A. | Chief Tech/Sci/R&D Officer | 28-03-2022 |
| Boston University | Corporate Officer/Principal | - |
Sapientia Pharmaceuticals, Inc.
 Sapientia Pharmaceuticals, Inc. Medical DistributorsDistribution Services Sapientia Pharmaceuticals, Inc. distributes pharmaceutical products. It develops novel targeted therapeutics for multiple indications including several cancers and fibrotic diseases. The company was founded by Douglas V. Faller and Robert M. Williams and is headquartered in Havertown, PA. | Founder | - |
Eerdere bekende functies van Douglas Faller
| Bedrijven | Functie | Einde |
|---|---|---|
Takeda Farmacéutica España SA
 Takeda Farmacéutica España SA Drugstore ChainsRetail Trade Part of Takeda Pharmaceutical Co., Ltd., Takeda Farmacéutica España SA is a pharmaceutical company based in Madrid, Spain. The Spanish company specializes in sales of pharmaceutical products. | Chief Tech/Sci/R&D Officer | - |
| VIRACTA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Founder | - |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
| The University of California, San Francisco | Corporate Officer/Principal | - |
Opleiding van Douglas Faller
| Harvard University | Doctorate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
| The University of California, San Francisco | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ORYZON GENOMICS S.A. | Health Technology |
| VIRACTA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Health Services |
HemaQuest Pharmaceuticals, Inc.
 HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology HemaQuest Pharmaceuticals, Inc. develops small molecule therapeutics. Its products include hydroxyurea, a therapeutic agent for the treatment of underlying pathology of sickle cell anemia and for the treatments of beta thalassemia, sickle cell anemia, neutropenia, and various hematological disorders. The company was founded by Ronald J. Berenson, Douglas V. Faller, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos and Robert Williams in October 2007 and is headquartered in San Diego, CA. | Health Technology |
Takeda Farmacéutica España SA
Takeda Farmacéutica España SA Drugstore ChainsRetail Trade Part of Takeda Pharmaceutical Co., Ltd., Takeda Farmacéutica España SA is a pharmaceutical company based in Madrid, Spain. The Spanish company specializes in sales of pharmaceutical products. | Retail Trade |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Health Technology |
Sapientia Pharmaceuticals, Inc.
Sapientia Pharmaceuticals, Inc. Medical DistributorsDistribution Services Sapientia Pharmaceuticals, Inc. distributes pharmaceutical products. It develops novel targeted therapeutics for multiple indications including several cancers and fibrotic diseases. The company was founded by Douglas V. Faller and Robert M. Williams and is headquartered in Havertown, PA. | Distribution Services |
